Revusiran
Product Specifications
UNSPSC Description
Revusiran (ALN-TTRSC) is a 1st-generation short interfering RNA, which directed against transthyretin (TTR) mRNA. Revusiran can be used for transthyretin (TTR)-mediated amyloidosis research[1].
Target Antigen
Small Interfering RNA (siRNA); Transthyretin (TTR)
Type
Oligonucleotides
Related Pathways
Epigenetics;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/revusiran.html
Solubility
10 mM in H2O
Smiles
[Revusiran]
Molecular Weight
16121.00
References & Citations
[1]Jessica E Sutherland, et al. Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis. Nucleic Acid Ther. 2020 Feb;30(1):33-49.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-132590/Revusiran-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-132590/
Clinical Information
Phase 3
CAS Number
1438322-82-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TL315416V 500 µL Each
C2orf60 (TYW5) Human shRNA Lentiviral Particle (Locus ID 129450)
Ask
View Details 
MBS1040194 Inquire
Recombinant Xenopus laevis Wee1-like protein kinase 2-A (wee2-a), partial
Ask
View Details